Dynavax(DVAX) - 2024 Q4 - Earnings Call Transcript

Dynavax (DVAX) Q4 2024 Earnings Call February 21, 2025 12:04 AM ET Company Participants Paul Cox - VP of Investor Relations & Corporate CommunicationsRyan Spencer - CEODonn Casale - Chief Commercial OfficerRobert Janssen - Chief Medical Officer and Senior VP of Clinical Development, Medical & Regulatory AffairsKelly MacDonald - CFOMatt Phipps - Group Head - BiotechnologyJonathan Miller - Managing Director Conference Call Participants Roy Buchanan - Equity Research AnalystPhil Nadeau - Managing Director, Hea ...